drugset / Trial / NCT01329276

Assess Particle Deposition and Acute Effects of Symbicort® Forte Turbohaler®) in COPD Patients.

NCT01329276

Phase 4 Completed 10 enrolled University Hospital, Antwerp AstraZeneca · collab
RandomizedCrossoverDouble-blindTreatment

Summary

Computational Fluid Dynamics (CFD) is a new functional imaging method. Since CFD is very sensitive to detect small changes, it might be worthwhile to study the acute effect of formoterol and budesonide combination therapy (Symbicort® forte Turbohaler®) on the upper airway dimensions in severe COPD patients (GOLD III). The increased sensitivity of this technique makes it possible to detect changes in airway caliber in early stages. The regional distribution of resistance and the change in this parameter will provide more insight into the mode of action of the product.

Timeline

Start
2010-06
Primary completion
2010-11
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 320 ug
Subject Formoterol Other / unclassified 9 ug